{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:51:14Z","timestamp":1791834674929,"version":"4.3.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,24]]},"DOI":"10.1097\/qad.0b013e32832d080d","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T19:49:22Z","timestamp":1250192962000},"page":"1701-1706","source":"Crossref","is-referenced-by-count":77,"title":["The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma"],"prefix":"10.1097","volume":"23","author":[{"given":"Mark","family":"Bower","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Newsom-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Powles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Boffito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gazzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210130","first-page":"250","article-title":"Kaposis sarcoma and Pneumocystis pneumonia among homosexual men: New York City and California.","volume":"30","year":"1981","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"R2-9-20210130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/0003-4819-96-6-693","article-title":"Disseminated Kaposi's sarcoma in homosexual men","volume":"96","author":"Friedman-Kien","year":"1982","journal-title":"Ann Intern Med"},{"key":"R4-9-20210130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00002018-199920050-00002","article-title":"A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma","volume":"20","author":"Nasti","year":"1999","journal-title":"Drug Saf"},{"key":"R5-9-20210130","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1200\/JCO.2001.19.18.3848","article-title":"Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy","volume":"19","author":"Holkova","year":"2001","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"R6-9-20210130","first-page":"S34","article-title":"Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study","volume":"21","author":"Jacobson","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-9-20210130","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R8-9-20210130","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-200307250-00001","article-title":"A comparison of regimens based on nonnucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma","volume":"17","author":"Portsmouth","year":"2003","journal-title":"AIDS"},{"key":"R9-9-20210130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R10-9-20210130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002030-200307250-00001","article-title":"A comparison of regimens based on nonnucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma","volume":"17","author":"Portsmouth","year":"2003","journal-title":"AIDS"},{"key":"R11-9-20210130","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-199910220-00014","article-title":"Highly active antiretroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma","volume":"13","author":"Bower","year":"1999","journal-title":"AIDS"},{"key":"R12-9-20210130","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)68649-2","article-title":"A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy","volume":"367","author":"Stebbing","year":"2006","journal-title":"Lancet"},{"key":"R13-9-20210130","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ijc.10274","article-title":"Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma","volume":"98","author":"Tam","year":"2002","journal-title":"Int J Cancer"},{"key":"R14-9-20210130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdn697","article-title":"The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease","volume":"20","author":"Powles","year":"2009","journal-title":"Ann Oncol"},{"key":"R15-9-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00042560-200206010-00015","article-title":"Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone","volume":"30","author":"Paparizos","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-9-20210130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00126334-200212010-00003","article-title":"Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma","volume":"31","author":"Gill","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-9-20210130","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0959-8049(99)00161-6","article-title":"Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome","volume":"35","author":"Cattelan","year":"1999","journal-title":"Eur J Cancer"},{"key":"R18-9-20210130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s15010-005-4099-z","article-title":"Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery","volume":"33","author":"Lichterfeld","year":"2005","journal-title":"Infection"},{"key":"R19-9-20210130","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1097\/00002030-200211220-00019","article-title":"The immunological effects of concomitant highly active antiretroviral therapy and liposomal anthracycline treatment of HIV-1-associated Kaposi's sarcoma","volume":"16","author":"Esdaile","year":"2002","journal-title":"AIDS"},{"key":"R20-9-20210130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1310\/700B-9QT3-HGN9-Q3FQ","article-title":"Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy","volume":"2","author":"Nunez","year":"2001","journal-title":"HIV Clin Trials"},{"key":"R21-9-20210130","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"R22-9-20210130","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification","volume":"15","author":"Krown","year":"1997","journal-title":"J Clin Oncol"},{"key":"R23-9-20210130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1468-1293.2008.00608.x","article-title":"British HIV Association guidelines for HIV-associated malignancies 2008","volume":"9","author":"Bower","year":"2008","journal-title":"HIV Med"},{"key":"R24-9-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R25-9-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomised clinical trials requiring prolonged observation of each patient II: analysis and examples","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"R26-9-20210130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.319.7201.23","article-title":"Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study","volume":"319","author":"Ledergerber","year":"1999","journal-title":"BMJ"},{"key":"R27-9-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"R28-9-20210130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS","volume":"99","author":"Biggar","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R29-9-20210130","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.bjc.6604520","article-title":"Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy","volume":"99","author":"Franceschi","year":"2008","journal-title":"Br J Cancer"},{"key":"R30-9-20210130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00042560-199910010-00017","article-title":"Development of Kaposi's sarcoma despite sustained suppression of HIV plasma viremia","volume":"22","author":"Chan","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-9-20210130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/QAD.0b013e3282f4de5d","article-title":"AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count","volume":"22","author":"Stebbing","year":"2008","journal-title":"AIDS"},{"key":"R33-9-20210130","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJMc070508","article-title":"HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load","volume":"357","author":"Maurer","year":"2007","journal-title":"N Engl J Med"},{"key":"R34-9-20210130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jcp.39.5.469","article-title":"Kaposi's sarcoma in acquired immune deficiency syndrome (AIDS)","volume":"39","author":"Francis","year":"1986","journal-title":"J Clin Pathol"},{"key":"R35-9-20210130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1746-1596-3-31","article-title":"Histological variants of cutaneous Kaposi sarcoma","volume":"3","author":"Grayson","year":"2008","journal-title":"Diagn Pathol"},{"key":"R36-9-20210130","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00002030-200005260-00010","article-title":"Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodeficience humaine","volume":"14","author":"Dupont","year":"2000","journal-title":"AIDS"},{"key":"R37-9-20210130","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2133.1999.02818.x","article-title":"The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma","volume":"140","author":"Dupin","year":"1999","journal-title":"Br J Dermatol"},{"key":"R38-9-20210130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00002030-199807000-00002","article-title":"Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma","volume":"12","author":"Lebbe","year":"1998","journal-title":"AIDS"},{"key":"R39-9-20210130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/QAD.0b013e328182df03","article-title":"Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART\/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma","volume":"21","author":"Bihl","year":"2007","journal-title":"AIDS"},{"key":"R40-9-20210130","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/QAD.0b013e3282ff6275","article-title":"Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response","volume":"22","author":"Nguyen","year":"2008","journal-title":"AIDS"},{"key":"R41-9-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm0302-225","article-title":"HIV protease inhibitors are potent antiangiogenic molecules and promote regression of Kaposi sarcoma","volume":"8","author":"Sgadari","year":"2002","journal-title":"Nat Med"},{"key":"R42-9-20210130","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1097\/00126334-199905010-00078","article-title":"HAART prolongs time to treatment failure (TTF) in Kaposi's sarcoma","volume":"21","author":"Bower","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R43-9-20210130","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.bjc.6603056","article-title":"Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy","volume":"94","author":"Martinez","year":"2006","journal-title":"Br J Cancer"},{"key":"R44-9-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2004.08.064","article-title":"Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma","volume":"22","author":"Krown","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200908240-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:09:17Z","timestamp":1618038557000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200908240-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,24]]},"references-count":42,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32832d080d","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,24]]}}}